The testing we provide is called Whole Exome Sequencing (WES). WES analyzes the protein-coding region of most genes in the human body which contains ~85% of all known disease-causing mutations. We report all pathogenic, likely pathogenic, and variants of uncertain significance associated with the patient’s reported symptoms.